Therapy Areas: Respiratory
CareDx highlights cardiothoracic advancements at ISHLT meeting
9 April 2024 -

Precision medicine solutions company CareDx Inc (NASDAQ: CDNA), known as The Transplant Company, reported on Tuesday that it presents its latest cardiothoracic advancements at the ISHLT 44th Annual Meeting & Scientific Sessions in Prague, Czech Republic, from 10 to 13 April 2024.

The presentations feature CareDx's cardiothoracic portfolio, including AlloSure Heart, AlloMap Heart, HeartCare, AlloSure Lung and AiCAV (in development), showcasing real-world applications in over 25 presentations.

Experts discuss the use of CareDx's solutions in clinical decision-making and managing real-world scenarios in two CareDx sponsored symposia, highlighting innovations in heart and lung transplantation care.

Headquartered in Brisbane, California, CareDx is focused on developing high-value healthcare solutions for transplant patients and caregivers, offering testing services, products and digital healthcare solutions.